Radius Health (RDUS) Tops Q2 EPS by 7c

Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($0.59), $0.07 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $674 million versus the consensus estimate of $693.9 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Bitzero reserves 33 hectares in Finland for data center expansion
• Crescent Biopharma (CBIO) Reiterated at Buy by Stifel on CR-003/SKB105 Potential